![Koji Hagimoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Koji Hagimoto
Hoofd Techniek/Wetenschap/O&O bij Anaeropharma Science, Inc.
Actieve functies van Koji Hagimoto
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Koji Hagimoto
Statistieken
Internationaal
Japan | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Koji Hagimoto
- Ervaring